Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.

Source:http://linkedlifedata.com/resource/pubmed/id/8881454

Download in:

View as

General Info

PMID
8881454